Most Popular Products
40mg Adalimumab Syringe
10999 INR/Piece
Product Details:
- Physical Form Liquid
- Dosage 40 mg /0.8 ml
- Dosage Guidelines As per suggestion
- Suitable For Suitable For All
- Storage Instructions Dry Place
- Click to View more
X
40mg Adalimumab Syringe Price And Quantity
- 1 Piece
- 10999 INR/Piece
40mg Adalimumab Syringe Product Specifications
- Liquid
- As per suggestion
- 40 mg /0.8 ml
- Dry Place
- Suitable For All
40mg Adalimumab Syringe Trade Information
- Cash in Advance (CID)
- 5000 Piece Per Month
- 7 Days
- All India
Product Description
Get relief from conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohns disease, ulcerative colitis, and plaque psoriasis with the 40mg Adalimumab Syringe. This liquid medication is to be administered in a dosage of 40 mg/0.8 ml as per suggestion and is suitable for all individuals. It is recommended to store this syringe in a dry place to maintain its efficacy. As an exporter, supplier, trader, and wholesaler, we ensure that the product is of the highest quality and meets all safety standards.
FAQs of 40mg Adalimumab Syringe:
Q: What are the common uses of this medication?
A: This medication is commonly used to treat conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohns disease, ulcerative colitis, and plaque psoriasis.Q: How should the 40mg Adalimumab Syringe be stored?
A: It should be stored in a dry place to maintain its efficacy.Q: What is the recommended dosage for this medication?
A: The recommended dosage is 40 mg/0.8 ml as per suggestion.Q: Is this medication suitable for all individuals?
A: Yes, it is suitable for all individuals.Q: What is the business type of the supplier?
A: The supplier is an exporter, supplier, trader, and wholesaler.Tell us about your requirement

Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Rheumatoid Arthritis Medicine' category
![]() |
EVAQO PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |